Objective Use of the frailty index to measure an accumulation of deficits has been proven a
valuable method for identifying elderly people at risk for increased vulnerability, disease …

Myasthenia gravis (MG) is an autoimmune disease characterized by muscle weakness and
fatiguability of skeletal muscles. It is an antibody-mediated disease, caused by …

Muscle weakness and fatigue are the hallmarks of autoimmune neuromuscular junction
disorders. Although a plethora of immunosuppressive treatments exist, no cure is available …

Myasthenia gravis (MG) is an autoimmune disease of the neuromuscular junction (NMJ).
Autoantibodies target key molecules at the NMJ, such as the nicotinic acetylcholine receptor …

Myasthenia gravis (MG) is an autoantibody-mediated disease that compromises the
acetylcholine receptors or associated structures of the postsynaptic membrane of the …

Myasthenia gravis (MG) is the most common autoimmune disorder affecting the
neuromuscular junction, characterized by skeletal muscle weakness and fatigability. It is …

Introduction Our aim in this study was to identify the prevalence and clinical characteristics of
LRP4/agrin‐antibody–positive double‐seronegative myasthenia gravis (DNMG). Methods …

Myasthenia gravis (MG) is a neurological autoimmune disorder characterized by muscle
weakness and fatigue. It is a B cell–mediated disease caused by pathogenic antibodies …

Recent advances in the understanding of autoantibody functionalities are bringing
neuroimmunologists closer to a more detailed appreciation of the mechanisms that govern …

During aging, acetylcholine receptor (AChR) clusters become fragmented and denervated at
the neuromuscular junction (NMJ). Underpinning molecular mechanisms are not well …